Sowmya Uttam
Domainex is satisfied to declare that a group of its researchers, working in close organization with Professor Michael Schneider and his group at Imperial College have discovered a possible new medication for treating the heart harm brought about by a cardiovascular failure by focusing on the manner in which the heart responds to pressure. The examination was distributed in the diary, Cell Stem Cell, and was part-financed by the British Heart Foundation (BHF). The examination group utilized undifferentiated cells to develop heart tissue and copy a 'coronary failure in a dish' and had the option to obstruct the synthetic signs inside heart muscle that lead to cell passing and heart harm.
इस लेख का हिस्सा
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu 